Etalocib (LY293111), an orally active leukotriene B4 receptor antagonist, inhibits the binding of [3H]LTB4, with a Ki of 25 nM. Etalocib (LY293111) prevents LTB4-induced calcium mobilization with an lC50 of 20 nM. Etalocib (LY293111) induces apoptosis[1][2][3].
Molecular Weight:
544.61
Purity:
99.03
CAS Number:
[161172-51-6]
Formula:
C33H33FO6
Target:
Apoptosis,Leukotriene Receptor
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted